About
Find Out More About Us

At the core of JM Innovate Venture's activity.
We belive that excellence in business performance through active ESG policies is key to fulfilling our commitment to investors and society. Our mid-terms ESG Strategy, approved by the Board, leverages technology and various firm areas, and is based on four pillars from corporate ESG integration to core investment activities. This approach enhances our business resilience and creates long-term value for investors, solidifying our role as a trusted advisor.
-
Climate Responsability
-
Social Responsability
-
Contribution to Society
About
International Network

-
Headquarter
-
JM Innovate Venture Scope
Strategies
Check Our Strategies
Set the Foundation at Seed
We collaborate with visionary scientists to transform breakthrough ideas into exceptional companies . By providing seed founding, we support entrepreneurs in validating and de-risking their scientific concepts. This partnership not only enhances value but also clarifies the best path for clinical development. Together, we lay a strong foundation for future success, and ensuring that innovative ideas have the resources and guidance they need to thrive.
Best-in-Class and/or First-in-Class Therapeutics
We invest in cutting-edge science with the potential to deliver best-in-class and/or first-in-class therapeutics the transform patient lives. While primarily focused on therapeutics, we will also selectively found medical device companies advancing transformative technology.
Anticipating the next wave of medical breakthroughs
We are deeply embeded in the pharmaceutical industry, backed by a premier network of contacts and advisors. With or first-hand market insights, we can foresee emerging therapeutic trends and identify growing areas of interest across a wide range of indications.
Follow throught hands on
When we invest, we contribute more than capital. Our team collaborates closely
with entrepreneurs, operationalizing capital to become true sweat equity partners. We embed industry
veterans to guide the company's growth and attract top talent.
With deep respect for people and science, we work to bring patients with serious diseases closer to
transformative cures.

Portfolio
Check Our Portfolio
Team
Our Hardworking Team

Mònica Pujadas
CEO & Founder
Jose Peñalver
Investor & Analyst I+D
Marcos Ventura
Analyst
María Romero
Chief Client Officer
Roger Prats
Analyst
David Jiménez
Consultant
Marta Del Potro
Operations Manager
Neus Ferrer
AnalystContact
Need Help? Contact Us
Address
Via Augusta 158, Barcelona
Call Us
93 611 270 999
Email Us
jminnovateventures@jim.com